Clinical Trials in Pittsburgh

Showing 2801-2820 of 10,050 trials

Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care

NCT04178096

This Veteran Affairs (VA) Quality Improvement project aims to understand which data-driven implementation strategies promote evidence based practices that improve high-quality care for Veterans with cirrhosis.

Cirrhosis, Liver

VA Office of Research and Development12 participantsStarted Sep 2020

Pittsburgh, Pennsylvania, United States

RECRUITINGNA< 1 mile

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

NCT05535192

This research is being done to assess whether an exercise intervention with protein intake support vs a health education and support program will make it easier for women age 65 or older who are receiving chemotherapy for breast cancer to receive all of their planned chemotherapy according to schedule and at the planned dose.

Breast CancerStage III Breast CancerBreast Cancer Female+2 more

Dana-Farber Cancer Institute270 participantsStarted Mar 2023

Boston, Massachusetts, United States • Cleveland, Ohio, United States • Pittsburgh, Pennsylvania, United States

Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

Find Trials by Condition in Pittsburgh

Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

Antibiotic Prophylaxis Before Shock Wave Lithotripsy

Strength or Power Training for Patellofemoral Pain

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Outcome of Patients with Severe Functional TR According to Medical, Transcatheter or Surgical Treatment

Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey

TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk

Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer

Noninvasive Monitoring of Uterine Activity and Fetal Heart Rate

A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants